Crossmark

Valutazione degli effetti del cabozantinib nel carcinoma tiroideo differenziato radioiodio refrattario nel trial di fase 3 “COSMIC-311”

Published Online: 2022-03-03

Published Print: 2022-04

Authors

Gusmano, Carmelo

Calogero, Aldo E.
License Information

Text and Data Mining valid from 2022-03-03

Version of Record valid from 2022-03-03
More Information

Article History

Accepted: 27 November 2021

First Online: 3 March 2022

Change Date: 22 July 2022

Change Type: Update

Change Details: Funding Note has been added.

Document is current